Liu Shiguo, Wang Xueqin, Zou Hui, Ge Yinlin, Wang Fang, Wang Yangang, Yan Shengli, Xia Hongfei, Xing Mingzhao
Prenatal Diagnosis Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Genetic Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Oncotarget. 2017 Jan 31;8(5):8707-8716. doi: 10.18632/oncotarget.14419.
Based on mutations in PAX8 is associated with thyroid dysgenesis. We aim to identify and characterize PAX8 mutations in a large cohort of congenital hypothyroidism(CH) from thyroid dysgenesis in Chinese population.
We screened 453 unrelated Chinese patients with CH from thyroid dysgenesis for PAX8 mutations by sequencing the whole coding regions of PAX8 on genomic DNA isolated from blood. Cell transfection assays using various vector constructs and induced mutagenesis as well as electrophoretic mobility shift assays were used to investigate the effects of selected mutations on the transcribing and binding activities of PAX8 at the promoters of target genes for thyroglobulin (TG) and thyroperoxidase (TPO).
Five PAX8 mutations were found, yielding a mutation prevalence of 5/453 (1.1%). We selected two mutations in the critical paired domain of PAX8 and generated mutants D94N and G41V. We demonstrated G41V was unable to bind the specific sequence in the promoters of TG and TPO and activate them. D94N could bind to TG and TPO promoters and normally activate the TG promoter transcription but not the TPO promoter transcription. We also demonstrated a dominant negative role of the PAX8 mutants in impairing the function of the wild-type PAX8.
We for the first time documented the prevalence and characterized the function of PAX8 mutations in CH in Chinese population. The study specifically demonstrated the role of novel mutations D94N and G41V in impairing the function of PAX8, providing further evidence for genetic PAX8 defects as a disease mechanism in CH.
基于PAX8基因突变与甲状腺发育不全相关。我们旨在在中国人群中,对一大群源于甲状腺发育不全的先天性甲状腺功能减退症(CH)患者进行PAX8基因突变的鉴定和特征分析。
我们对453名源于甲状腺发育不全的中国CH患者进行了筛查,通过对从血液中分离的基因组DNA上的PAX8全编码区进行测序来检测PAX8基因突变。使用各种载体构建体进行细胞转染试验、诱导诱变以及电泳迁移率变动分析,以研究所选突变对PAX8在甲状腺球蛋白(TG)和甲状腺过氧化物酶(TPO)靶基因启动子处的转录和结合活性的影响。
发现了5个PAX8基因突变,突变发生率为5/453(1.1%)。我们在PAX8的关键配对结构域中选择了两个突变,并生成了D94N和G41V突变体。我们证明G41V无法结合TG和TPO启动子中的特定序列并激活它们。D94N可以结合TG和TPO启动子,并正常激活TG启动子转录,但不能激活TPO启动子转录。我们还证明了PAX8突变体在损害野生型PAX8功能方面具有显性负性作用。
我们首次记录了中国人群CH中PAX8基因突变的发生率并对其功能进行了特征分析。该研究特别证明了新突变D94N和G41V在损害PAX8功能方面的作用,为PAX8基因缺陷作为CH的一种疾病机制提供了进一步的证据。